Fujii Takaaki, Yajima Reina, Morita Hiroki, Hirakata Tomoko, Miyamoto Takeshi, Fujisawa Tomomi, Tsutsumi Soichi, Ynagita Yasuhiro, Iijima Misa, Kuwano Hiroyuki
Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Gunma, Japan.
Am Surg. 2015 May;81(5):523-6.
The presence of lymph node metastasis is considered to be the most significant indicator of prognosis. However, in some cases with node-positive breast cancer, cancer cell dissemination is localized to the lymphatic systems. It is, therefore, important to develop selection criteria for strong adjuvant therapy in patients with node-positive breast cancer. This study was undertaken to evaluate the presence of vascular invasion that may reflect systemic disease as a predictor of disease recurrence in node-positive breast cancer. We retrospectively evaluated the cases of 134 consecutive female patients with breast cancer with lymph node metastasis who underwent radical breast operations. We examined the relationship between recurrence and clinicopathological factors, particularly vascular invasion. The presence of vascular invasion was found to be significant in a univariate analysis. The presence of vascular invasion was the independent risk factor in a multivariate analysis. Among the 66 patients without vascular invasion, four (6.1%) had disease recurrence. On the other hand, among the 68 patients with vascular invasion, 15 (22.1%) had a recurrence. It is interesting to note that despite the presence of lymph node metastasis, the group without vascular invasion had few patients with distant metastases. Our results suggest that the presence of vascular invasion could be an indicator of high biological aggressiveness and may be a strong prognostic factor for node-positive breast cancer.
淋巴结转移的存在被认为是预后的最重要指标。然而,在一些淋巴结阳性乳腺癌病例中,癌细胞扩散局限于淋巴系统。因此,制定针对淋巴结阳性乳腺癌患者进行强化辅助治疗的选择标准很重要。本研究旨在评估血管侵犯的存在情况,其可能反映全身疾病,作为淋巴结阳性乳腺癌疾病复发的预测指标。我们回顾性评估了134例连续接受乳腺癌根治术的伴有淋巴结转移的女性乳腺癌患者的病例。我们研究了复发与临床病理因素之间的关系,特别是血管侵犯。在单因素分析中,血管侵犯的存在具有显著性。在多因素分析中,血管侵犯的存在是独立危险因素。在66例无血管侵犯的患者中,4例(6.1%)出现疾病复发。另一方面,在68例有血管侵犯的患者中,15例(22.1%)复发。值得注意的是,尽管存在淋巴结转移,但无血管侵犯组远处转移的患者很少。我们的结果表明,血管侵犯的存在可能是高生物学侵袭性的一个指标,并且可能是淋巴结阳性乳腺癌的一个强有力的预后因素。